0.875
0.016 (1.86%)
0.016 (1.86%)
Upgrade to Real-Time
Afterhours (Closed)
Low
0.66
High
2.22
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Matinas Biopharma Holdings Inc | MTNB | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.016 | 1.86% | 0.875 | 19:56:06 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.87 | 0.85 | 0.875 | 0.8738 | 0.859 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,387 | 664,570 | $ 0.8633721 | $ 573,771 | 1,119,885 | 0.66 - 2.22 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 20:00:00 | 919 | $ 0.8738 | USD |
Matinas Biopharma Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 178.75M | 204.28M | 196.50M | $ 158.33k | $ - | -0.12 | -7.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 7.56k | 5.40% |
Matinas Biopharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MTNB Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.83 | 0.8802 | 0.8066 | 0.8395478 | 1,107,658 | 0.045 | 5.42% |
| 1 Month | 0.74 | 0.8802 | 0.73 | 0.8055206 | 1,006,384 | 0.135 | 18.24% |
| 3 Months | 1.14 | 1.195 | 0.7207 | 0.9189021 | 1,280,604 | -0.265 | -23.25% |
| 6 Months | 1.05 | 2.22 | 0.7207 | 1.29 | 3,730,202 | -0.175 | -16.67% |
| 1 Year | 0.85 | 2.22 | 0.66 | 1.13 | 2,987,371 | 0.025 | 2.94% |
| 3 Years | 0.59 | 2.49 | 0.3237 | 1.09 | 2,020,383 | 0.285 | 48.31% |
| 5 Years | 3.99 | 4.35 | 0.3237 | 1.13 | 1,517,763 | -3.12 | -78.07% |
Matinas Biopharma Description
| Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others. |
